q-line biotech private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 17 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 26 bids — BIOSCI HEALTH CARE appeared in 7 of them.
Q-LINE BIOTECH PRIVATE LIMITED
Q-LINE BIOTECH PRIVATE LIMITED
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
216
Contract Value
₹401.37 Cr
L1 Bids
27
Recent Win Rate
16.0%
Performance Analytics
Q-Line Biotech Government Tender Profile
With a substantial portfolio of 216 government tender participations, Q-Line Biotech Private Limited has demonstrated strategic engagement in India's public procurement landscape. This analysis provides insights into their bidding performance, tender success patterns, and competitive positioning in government contracts.
Proven L1 Bid Success with 27 Contract Wins
Q-Line Biotech has successfully secured 27 L1 positions in government tenders, demonstrating their strategic pricing approach and competitive bid strategy. With a win ratio of 12.5% across 216 tender participations, they have established a reliable track record in government procurement. Their bidding performance also includes 0 L2 and 0 L3 rankings, showing consistent competitiveness in public sector contracts.
Notably, Q-Line Biotech has demonstrated capability in high-value government contracts, participating in 22 major procurement projects. This experience with premium government tenders indicates their capacity to handle significant public sector work and complex project requirements.
Financial Performance in Government Tenders
Q-Line Biotech has bid on contracts with a total value of ₹4,01,36,79,067.0, successfully securing ₹4,01,36,79,067.0 in government contract value. This represents a 100.0% conversion rate of bid value to won contracts, demonstrating their effectiveness in targeting and securing valuable public sector projects.
The company's average Earnest Money Deposit (EMD) of ₹1,25,000.0 indicates their financial capacity to participate in substantial government tenders requiring significant bid security.